Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs (Q39557809)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 October 2012

Language	Label	Description	Also known as
English	Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs	scientific article published on 24 October 2012

Statements

scholarly article

1 reference

Europe PubMed Central

13 September 2017

Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs (English)

1 reference

Europe PubMed Central

13 September 2017

anti-retroviral agent

0 references

Sub-Saharan Africa

0 references

Emmanuela Gakidou

4

object named as

Emmanuela Gakidou

1 reference

Europe PubMed Central

13 September 2017

Christopher J.L. Murray

3

object named as

Christopher J L Murray

1 reference

Europe PubMed Central

13 September 2017

Joshua A Salomon

5

object named as

Joshua A Salomon

1 reference

Europe PubMed Central

13 September 2017

author name string

Stéphane Verguet

1

1 reference

Europe PubMed Central

13 September 2017

Stephen S Lim

2

1 reference

Europe PubMed Central

13 September 2017

language of work or name

0 references

publication date

24 October 2012

1 reference

Europe PubMed Central

13 September 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

13 September 2017

207

1 reference

Europe PubMed Central

13 September 2017

1

1 reference

Europe PubMed Central

13 September 2017

72-79

1 reference

Europe PubMed Central

13 September 2017

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Overestimates of survival after HAART: implications for global scale-up efforts

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Trends in retention on antiretroviral therapy in national programs in low-income and middle-income countries

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Long-term costs and health impact of continued global fund support for antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Antiretroviral therapy and early mortality in South Africa

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Sustained immunological responses to highly active antiretroviral therapy at 36 months in a Ghanaian HIV cohort

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites with comprehensive monitoring availability.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Comparison of methods to correct survival estimates and survival regression analysis on a large HIV African cohort.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

The need for double-sampling designs in survival studies: an application to monitor PEPFAR

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Universal access: the benefits and challenges in bringing integrated HIV care to isolated and conflict affected populations in the Republic of Congo.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

HIV treatment in a conflict setting: outcomes and experiences from Bukavu, Democratic Republic of the Congo

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Challenges for scaling up ART in a resource-limited setting: a retrospective study in Kibera, Kenya

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Youth, unemployment, and male gender predict mortality in AIDS patients started on HAART in Nigeria

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Adult clinical and immunologic outcomes of the national antiretroviral treatment program in Rwanda during 2004-2005.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Mortality and loss to follow-up among HAART initiators in rural South Africa.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Two-year virologic outcomes of an alternative AIDS care model: evaluation of a peer health worker and nurse-staffed community-based program in Uganda

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Identifiers

10.1093/INFDIS/JIS635

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39557809&oldid=1929809185"